Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer

• Aida Bao-Caamano,
• Nicolás Costa-Fraga,
• Laure Cayrefourcq,
• María Amalia Jácome,
• Aitor Rodriguez-Casanova,
• Laura Muinelo-Romay,
• Rafael López-López,
• Catherine Alix-Panabières,
• Angel Díaz-Lagares

Affiliations

Aida Bao-Caamano

Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS)

Nicolás Costa-Fraga

Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS)

Laure Cayrefourcq

Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, IURC

María Amalia Jácome

Department of Mathematics, MODES Group, CITIC, Faculty of Science, Universidade da Coruña

Aitor Rodriguez-Casanova

Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS)

Laura Muinelo-Romay

Galician Precision Oncology Research Group (ONCOGAL), Medicine and Dentistry School, Universidade de Santiago de Compostela (USC)

Rafael López-López

Galician Precision Oncology Research Group (ONCOGAL), Medicine and Dentistry School, Universidade de Santiago de Compostela (USC)

Catherine Alix-Panabières

Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, IURC

Angel Díaz-Lagares

Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS)